1. Rosner B. Fundamentals of Biostatistics. 7th ed.Cengage Learning;2000. p. 666–673.
2. Patterson S, Jones B. In: Keidling N (ed) Bioequivalence and Statistics in Clinical Pharmacology. Chapman and Hall/CRC, Boca Raton. 2006. 39–77.
3. Wallenstein S, Fisher AC. The analysis of two-period repeated measurements crossover design with application to clinical trials. Biometrics. 1977; 33:261–269.
4. Woods JR, Williams JG, Tavel M. The two-period crossover design in medical research. Ann Intern Med. 1989; 110:560–566.
Article
5. Cheng J, Olbricht G, Gunaratna N, Kendall R, Lipka A, Paul S, et al. Mixed Models,. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.136.77. 49&rep=rep1&type=pdf, Accessed 29 October. 2014.
6. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics. 1986; 42:805–820.
Article
7. Wolfinger RM, Chang M. Comparing the SAS® GLM and MIXED Procedures for Repeated Measures,. http://www.ats.ucla.edu/stat/sas/library/mixedglm.pdf. Accessed 29 October. 2014.
8. Montgomery DC. Design and Analysis of Experiment, John Wiley & Sons. 1984. 71.
9. Park SH. Design of Experiments, Min-Young-SA. 2006. 58.
10. Meyers LS, Gamst G, Guarino AJ. Applied Multivariate Research, Design and Interpretation, Sage. 2006. 279–314.
11. Owen JS, Fiedler-Kelly J. Introduction to Population Pharmacokinetic/Pharmacodynamic Analysis with Nonlinear Mixed Effects Models, Wiley, New York. 2014. 9–29.
12. Brunelle R. Review various methods to perform the analysis of a 2 treatment, 2 period crossover study. http://www.math.iupui.edu/∼indyasa/crosover.pdf. Accessed 29 October. 2014.
13. SAS. 2014. ).,. http://support.sas.com/onlinedoc/913/getDoc/en/statug.hlp/glm_sect34.htm. Accessed 29 October 2014.
14. Saarinen F. Using mixed models in a crossover study with repeated measurements within periods,. http://www2.math.su.se/matstat/reports/se-rieb/2004/rep22/report.pdf. Accessed 29 October. 2014.
15. OehLert GW. A few words about REML. http://users.stat.umn.edu/∼corbett/classes/5303/REML.pdf. Accessed 29 October. 2014.
16. Pinheiro CJ, Bates DM. Mixed-Effects Models in S and S-PLUS. Springer;2004. p. 57–82.
17. Kiernan K, Tao J, Gibbs P. Tips and strategies for mixed modeling with SAS/Stat procedures, SAS global forum 2012,. http://support.sas.com/resources/papers/proceedings12/332–2012.pdf. Accessed 29 October. 2014.
18. Frison L, Pocock SJ. Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design. Stat Med. 1992; 11:1685–1704.
Article
19. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters III. Monoexponential model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm. 1983; 11:303–319.
Article
20. Mauchly JW. Significance test for sphericity of a normal n-variate distribution. Annals of Mathematical Statistics. 1940; 11:204–209.
Article
21. Anderson TW. An Introduction to Multivariate Statistical Analysis. New York: John Wiley & Sons, Inc.;1984. p. 440–442.
22. Huynh H, Feldt LS. Conditions under Which Mean Square Ratios in Repeated Measurements Designs Have Exact F-Distribution. Journal of the American Statistical Association. 1970; 65:1582–1589.
23. Sakamoto Y, Ishiguro M, Kitagawa G. Akaike information criterion statistics. Psychometrika. 1986; 54:539–541.
24. Schwarz G. Estimating the dimension of a model. Ann Statistics. 1978; 6:461–464.
Article